Unaudited Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 213,880	$ 247,862
Accounts receivable, net of allowance for doubtful accounts of $66,000	667	1,032,886
Other current assets	15,531	5,934
Total current assets	230,078	1,286,682
Patents, net of accumulated amortization of $3,280,936 and $2,266,158, respectively	1,786,172	2,200,959
Total assets	2,016,250	3,487,641
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Accounts payable and accrued liabilities	112,295	2,892,025
Loans payable	138,000	147,000
Purchase price of patents, net of unamortized discount of $57,252 and $0, respectively	1,927,797	1,500,000
Funding liability	3,150,000
Loan payable – related party	2,805,000	4,672,810
Warrant liability	1,934,550
Accrued interest	413,798	288,445
Total current liabilities	10,481,440	9,500,280
Loan Payable – Small Business Association (SBA)	150,000	170,832
Purchase price of patents, net of unamortized discount of $0 and $131,793, respectively, net of current portion	190,000	658,207
Total liabilities	10,821,440	10,329,319
Stockholders’ deficit:
Preferred stock, par value $.00003 per share, authorized 10,000,000 shares, no shares issued and outstanding
Common stock, par value $0.00003 per share; authorized 10,000,000,000 shares at September 30, 2021 and December 31, 2020; shares issued and outstanding 533,334,630 and 383,038,334 at September 30, 2021 and December 31, 2020, respectively	16,000	11,491
Additional paid-in capital	17,437,580	14,427,782
Accumulated deficit	(26,258,998)	(21,281,179)
Total Quest Patent Research Corporation deficit	(8,805,418)	(6,841,906)
Non-controlling interest in subsidiary	228	228
Total stockholders’ deficit	(8,805,190)	(6,841,678)
Total liabilities and stockholders’ deficit	$ 2,016,250	$ 3,487,641